Clarke, N.W., Ali, A., Ingleby, F.C., Hoyle, A., Amos, C.L., Attard, G., et al. (2019) Addition of Docetaxel to Hormonal Therapy in Low- and High-Burden Metastatic Hormone Sensitive Prostate Cancer: Long-Term Survival Results from the Stampede Trial. Annals of Oncology, 30, 1992-2003.
https://doi.org/10.1093/annonc/mdz248.001

has been cited by the following article:

• TITLE: A Shoulder Mass Revealing a Metastatic Prostate Cancer

  AUTHORS: Kanta Ka, Mohamed Jalloh, Babacar Sine, Oumar Gaye, Awa Sadikh Badiane, Ibrahima Thiam, Mamadou Moustapha Dieng, Papa Macoumba Gaye

  KEYWORDS: Shoulder, Prostate, Cancer, Metastasis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.10 No.4, April 27, 2021

  ABSTRACT: Introduction: A shoulder mass revealing metastatic prostate cancer is very rare. We report a case of metastatic prostate cancer diagnosed on a shoulder mass and treated with analgesic radiotherapy and chemotherapy and androgen deprivation therapy (ADT). Observations: A 66 years old patient was referred for a painful right shoulder mass whose biopsy and pathological examination found a Gleason 8 (4 + 4) moderately differentiated adenocarcinoma. The PSA level was 508.52 ng/ml. The patient was treated with analgesic radiotherapy on the right shoulder and chemo-hormonal therapy. At 2 years follow-up, the disease was well controlled. Conclusion: A shoulder mass revealing metastatic prostate cancer is not common. Local treatment of the symptomatic metastasis while continuing chemotherapy and ADT improves the quality of life.